TrialFind
Saved trials
Back to results
Terminated
Phase 2
Effects Of Rosiglitazone (Extended Release Tablets) On Cerebral Glucose Utilisation And Cognition Alzheimers Disease
NCT00334568
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
GSK Investigational Site
Cambridge, Cambridgeshire, United Kingdom
View on ClinicalTrials.gov
Official details
Effects Of Rosiglitazone (Extended Release Tablets) On Cerebral Glucose Utilisation And Cognition Alzheimers Disease — TrialFind